US researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.
John Michael Finnegan "Finn" McGrath, age sixteen months, watches as his mother reads to him in 2011. US researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.
The phase I trial follows promising studies on mice showing that such transplants were able to rebuild the structures of the inner ear, and some anecdotal evidence from humans, sparking hope of a cure for some forms of deafness.
This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.
About the author
- Writer: AFP News agency
- Position: Agence France-Presse
Latest stories in this category:
- 'Device' claim triggers France-US flight diversion
- Cyber crooks cranking out new weapons experts warn
- Bank of Japan keeps ultra-low rates unchanged
- China must act to prevent hard landing: World Bank
- EU leaders open eurobonds debate at 'growth' summit
- Egyptians vote in historic presidential election
- Britain field hockey team seek Olympic tune-up
- SpaceX blasts off to space station in historic first
